Lung Adenocarcinoma Harboring Mutations in the ERBB2 Kinase Domain

This publication has 22 references indexed in Scilit:

• ERBB2 kinase domain mutation in the lung squamous cell carcinoma
  Cancer Letters, 2006
• EGFR and erbB2 mutation status in Japanese lung cancer patients
  International Journal of Cancer, 2005
• Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer
  Clinical Cancer Research, 2005
• Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
  JNCI Journal of the National Cancer Institute, 2005
• Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy
  Cell Research, 2005
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers
  Oncogene, 2002
• Epidermal growth factor receptor expression, signal pathway, and inhibitors in non[ndash ]small cell lung cancer
  Seminars in Oncology, 2002